Advanced institutional buyers in the “beyond the pill” strategic segment increasingly demand that firms guarantee outcome rates. Producers of pharmaceutical products also need to integrate their products with personalized healthcare and remote monitoring technologies. In the consumer-facing “wellness” strategic segment, buyers expect producers to integrate medicinal and emotionalbenefits in product packaging and marketing. They will also expect the...
Voir la suite
Document also available in :
anglais
INFORMATION
-
2021/11/10
-
Fiche
-
150125
-
1
-
1
-
2021/11/11
-
Disclosed
-
Croatia : Pharmaceuticals, Biopharmaceuticals, Medical Devices, and Equipment